Table 2. Factors Associated With Receipt of CRT in the 6900 Study Patients.
Factor | Multivariate Analysis for Receiving CRT, Adjusted Odds Ratio (95% CI)a |
---|---|
Age, y | |
≤50 | 1 [Reference] |
51-60 | 1.18 (0.99-1.40) |
61-70 | 1.24 (1.04-1.49) |
>70 | 1.38 (1.15-1.68) |
Sex | |
Female | 1 [Reference] |
Male | 1.31 (1.16-1.49) |
Year of diagnosis | |
2004-2006 | 1 [Reference] |
2007-2009 | 0.79 (0.68-0.91) |
2010-2012 | 0.48 (0.42-0.46) |
Distance, miles | |
<10 | 1 [Reference] |
10-19 | 0.63 (0.54-0.74) |
20-29 | 0.67 (0.55-0.81) |
≥30 | 0.49 (0.42-0.57) |
Facility | |
Academic | 1 [Reference] |
Comprehensive community cancer program | 2.65 (2.33-3.01) |
Community or integrated network cancer program | 2.54 (2.15-3.01) |
Unknown | 1.04 (0.72-1.49) |
Comorbidity index | |
1 | 1 [Reference] |
2 | 0.60 (0.51-0.71) |
3 | 0.81 (0.61-1.06) |
Clinical T stage | |
cT1-cT2 | 1 [Reference] |
cT3-cT4a | 2.11 (1.85-2.41) |
Clinical N stage | |
cN0-cN1 | 1 [Reference] |
cN2a-cN2c | 1.81 (1.62-2.04) |
Site | |
Oral tongue | 1.78 (1.58-2.01) |
Other mouth | 1 [Reference] |
Abbreviation: CRT, chemoradiotherapy.
Multivariate model included age, sex, year of diagnosis, distance from facility, facility type, comorbidity index, clinical T stage, clinical N stage, and site.